VIVO BIO TECH LTD.

NSE : NABSE : 511509ISIN CODE : INE380K01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE45.590.61 (+1.36 %)
PREV CLOSE ( ) 44.98
OPEN PRICE ( ) 43.31
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8205
TODAY'S LOW / HIGH ( )43.31 46.00
52 WK LOW / HIGH ( ) 21.0556
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax46.2144.7286.2042.5318.25
Adjustment169.17114.4091.2182.7076.99
Changes In working Capital-33.6541.8329.02-10.06-80.82
Cash Flow after changes in Working Capital181.73200.95206.43115.1814.42
Cash Flow from Operating Activities148.34166.42141.7686.07-7.76
Cash Flow from Investing Activities-39.98-511.12-228.22-102.34-35.31
Cash Flow from Financing Activities-111.75350.1887.8320.937.18
Net Cash Inflow / Outflow-3.395.481.374.66-35.88
Opening Cash & Cash Equivalents17.1411.6610.295.6341.51
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent13.7517.1411.6510.295.63

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.